Literature DB >> 18182560

Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.

Mark A Richardson1, Akanksha Gupta, Lee A O'Brien, David T Berg, Bruce Gerlitz, Samreen Syed, Ganesh R Sharma, Martin S Cramer, Josef G Heuer, Elizabeth J Galbreath, Brian W Grinnell.   

Abstract

The protein C (PC) pathway plays an important role in vascular and immune function, and acquired deficiency during sepsis is associated with increased mortality in both animal models and in clinical studies. However, the association of acquired PC deficiency with the pathophysiology of lung injury is unclear. We hypothesized that low PC induced by sepsis would associate with increased pulmonary injury and that replacement with activated protein C (APC) would reverse the activation of pathways associated with injury. Using a cecal ligation and puncture (CLP) model of polymicrobial sepsis, we examined the role of acquired PC deficiency on acute lung injury assessed by analyzing changes in pulmonary pathology, chemokine response, inducible nitric-oxide synthase (iNOS), and the angiotensin pathway. Acquired PC deficiency was strongly associated with an increase in lung inflammation and drivers of pulmonary injury, including angiotensin (Ang) II, thymus and activation-regulated chemokine, plasminogen activator inhibitor (PAI)-1, and iNOS. In contrast, the protective factor angiotensin-converting enzyme (ACE)-2 was significantly suppressed in animals with acquired PC deficiency. The endothelial protein C receptor, required for the cytoprotective signaling of APC, was significantly increased post-CLP, suggesting a compensatory up-regulation of the signaling receptor. Treatment of septic animals with APC reduced pulmonary pathology, suppressed the macrophage inflammatory protein family chemokine response, iNOS expression, and PAI-1 activity and up-regulated ACE-2 expression with concomitant reduction in AngII peptide. These data demonstrate a clear link between acquired PC deficiency and pulmonary inflammatory response in the rat sepsis model and provide support for the concept of APC as a replacement therapy in acute lung injury associated with acquired PC deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182560     DOI: 10.1124/jpet.107.130609

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  Activated neutrophils in the initiation and progression of COVID-19: hyperinflammation and immunothrombosis in COVID-19.

Authors:  Xinyi Zhao; Lijin Zhou; Yan Kou; Junjie Kou
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1.

Authors:  Zhiyong Wu; Feifeng Dai; Wei Ren; Huagang Liu; Bowen Li; Jinxing Chang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

Review 3.  Protective mechanisms of activated protein C in severe inflammatory disorders.

Authors:  Arne P Neyrinck; Kathleen D Liu; James P Howard; Michael A Matthay
Journal:  Br J Pharmacol       Date:  2009-05-14       Impact factor: 8.739

Review 4.  The unique characteristics of COVID-19 coagulopathy.

Authors:  Toshiaki Iba; Jerrold H Levy; Jean Marie Connors; Theodore E Warkentin; Jecko Thachil; Marcel Levi
Journal:  Crit Care       Date:  2020-06-18       Impact factor: 9.097

Review 5.  Hematologic disorders associated with COVID-19: a review.

Authors:  Mandeep Singh Rahi; Vishal Jindal; Sandra-Patrucco Reyes; Kulothungan Gunasekaran; Ruby Gupta; Ishmael Jaiyesimi
Journal:  Ann Hematol       Date:  2021-01-07       Impact factor: 3.673

6.  Angiotensin II Blood Serum Levels in Piglets, after Intra-Dermal or Intra-Muscular Vaccination against PRRSV.

Authors:  Georgios Maragkakis; Labrini V Athanasiou; Laskarina-Maria Korou; Serafeim C Chaintoutis; Chrysostomos Dovas; Despina N Perrea; Georgios Papakonstantinou; Georgios Christodoulopoulos; Dominiek Maes; Vasileios G Papatsiros
Journal:  Vet Sci       Date:  2022-09-11

7.  Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep.

Authors:  Kristine Waerhaug; Mikhail Y Kirov; Vsevolod V Kuzkov; Vladimir N Kuklin; Lars J Bjertnaes
Journal:  Crit Care       Date:  2008-11-20       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.